Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DENND5B antisense RNA 1 (DENND5B-AS1) is a long non-coding RNA located on chromosome 12. It does not encode a protein and is categorized as an antisense RNA overlapping the DENND5B gene. While its precise biological function remains incompletely characterized, it has been identified as an RNA species correlated with tumor staging and is considered a potentially risky prognostic marker in cancer molecular studies[2][9][8]. Like other lncRNAs, DENND5B-AS1 is presumed to act through regulation of gene expression, possibly influencing chromatin structure, transcription, or RNA stability[3]. DENND5B-AS1 is not considered a therapeutic target in the conventional sense, and there are no known drugs or therapies that directly modulate its activity. It is mainly studied as a biomarker for cancer prognosis and molecular classification[2][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DENND5B antisense RNA 1 (DENND5B-AS1).